Because YY1 inhibition by NO leads to the sensitization of cancer cells to both chemotherapy and immunotherapy [145], and YY1 mediates the expression of PD-L1 in tumor cells [35], NO may play a role in sensitizing tumor cells to anti-PD1/anti-PD-L1 therapy. The gene discussed is YY1; the disease is neoplasm.